Data from Pfizer/BioNTech, Moderna for COVID-19 vaccines ‘very robust’-EMA


The data submitted to the European Medicines Agency (EMA) by Pfizer/BioNTech and Moderna for their COVID-19 vaccine candidates is “very robust”, its executive director said on Thursday.

“We have a data set of over 30,000 subjects who have been followed through the clinical trials. This gives us a very robust data set on which to make a decision, both on safety and efficacy,” Emer Cooke said at a committee meeting of the European Parliament.

The agency is expected to complete reviews by Dec. 29 for the Pfizer/BioNTech vaccine and by Jan. 12 for the Moderna vaccine “at the latest”.

Cooke said that the approval decision dates could change, depending on the assessment.

“We cannot guarantee that there will be a positive outcome at this stage” Cooke said, adding that the agency’s experts had to examine very large data sets.

“We have to make sure we analyse those data correctly,” she said. US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.


Our new page here is just what you need, with just good news, feel good stories unrelated to COVID.

By Justgivemepositivenews Team